Literature DB >> 16195782

Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1.

S D Blackburn1, R A Steadman, F B Johnson.   

Abstract

Heparan sulfate proteoglycan is thought to act as primary receptor for adeno-associated virus type 2 (AAV-2). Reported coreceptors include alphaVbeta5 integrin, fibroblast growth factor receptor 1 (FGFR-1), and hepatocyte growth factor (c-Met). The interaction of AAV type 3 (AAV-3) with possible cell membrane receptors is incompletely defined. In this study, using assays detecting competition with viral infection, virus binding inhibition assays and dot blotting, we show attachment of AAV-3 strain H to heparin, heparan sulfate, and FGFR-1. These findings provide new information on the possible receptor array used by AAV-3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195782     DOI: 10.1007/s00705-005-0650-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9.

Authors:  Bassel Akache; Dirk Grimm; Kusum Pandey; Stephen R Yant; Hui Xu; Mark A Kay
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Fang Xie; Timra Gilson; Elliot J Androphy
Journal:  Virology       Date:  2018-06-06       Impact factor: 3.616

Review 3.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

4.  The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

Authors:  Thomas F Lerch; Qing Xie; Michael S Chapman
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

5.  Genome-wide association study of sepsis in extremely premature infants.

Authors:  Lakshmi Srinivasan; Grier Page; Haresh Kirpalani; Jeffrey C Murray; Abhik Das; Rosemary D Higgins; Waldemar A Carlo; Edward F Bell; Ronald N Goldberg; Kurt Schibler; Beena G Sood; David K Stevenson; Barbara J Stoll; Krisa P Van Meurs; Karen J Johnson; Joshua Levy; Scott A McDonald; Kristin M Zaterka-Baxter; Kathleen A Kennedy; Pablo J Sánchez; Shahnaz Duara; Michele C Walsh; Seetha Shankaran; James L Wynn; C Michael Cotten
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2017-03-10       Impact factor: 5.747

6.  Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.

Authors:  Chen Ling; Yuan Lu; Jasmine K Kalsi; Giridhara R Jayandharan; Baozheng Li; Wenqin Ma; Binbin Cheng; Samantha W Y Gee; Katherine E McGoogan; Lakshmanan Govindasamy; Li Zhong; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

7.  Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction.

Authors:  Emily L Messina; Jeffrey Nienaber; Mani Daneshmand; Nestor Villamizar; Jude Samulski; Carmelo Milano; Dawn E Bowles
Journal:  Hum Gene Ther       Date:  2012-08-27       Impact factor: 5.695

Review 8.  In vivo tissue-tropism of adeno-associated viral vectors.

Authors:  Arun Srivastava
Journal:  Curr Opin Virol       Date:  2016-09-03       Impact factor: 7.090

9.  Effects of Altering HSPG Binding and Capsid Hydrophilicity on Retinal Transduction by AAV.

Authors:  Sean M Crosson; Antonette Bennett; Diego Fajardo; James J Peterson; Hangning Zhang; Wei Li; Matthew T Leahy; Colin K Jennings; Ryan F Boyd; Sanford L Boye; Mavis Agbandge-McKenna; Shannon E Boye
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

10.  Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.

Authors:  Jason O'Donnell; Kenneth A Taylor; Michael S Chapman
Journal:  Virology       Date:  2009-01-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.